
A 41-year-old woman presented to the emergency department with acute respiratory failure as the initial manifestation of myasthenia gravis, bypassing typical ocular symptoms. The patient demonstrated Modified Medical Research Council Dyspnea Scale score of 4, positive anti-AChR antibodies, and nerve conduction abnormalities affecting multiple limb distributions. This case stresses the critical need for neurological assessment in unexplained acute respiratory presentations.
💡 Key Clinical Considerations
- Atypical presentation pattern: Acute respiratory distress preceded classic ocular manifestations, requiring high clinical suspicion for MG in unexplained dyspnea cases without clear cardiac or pulmonary etiology.
- Diagnostic confirmation: Nerve conduction studies revealed impaired neuromuscular transmission in upper extremities (elbow, forearm, wrist, fingers) and lower extremities (leg, foot, toes), with positive anti-AChR antibodies confirming diagnosis.
- Respiratory severity markers: Patient unable to complete full sentences in one breath, segmental atelectasis on imaging, and concurrent restrictive lung disease requiring immediate ICU admission and respiratory support.
- Neurological distribution: Sensory abnormalities along median nerve distribution accompanied motor deficits, demonstrating multifocal nerve involvement beyond respiratory muscle weakness characteristic of myasthenic crisis.
- Treatment response: Pyridostigmine initiation with supportive respiratory management and hypoxia correction produced favorable clinical recovery, validating prompt diagnosis and intervention approach.
🎯 Clinical Practice Impact
- Patient Communication: Educate patients with progressive dyspnea about neurological causes when cardiac and pulmonary workup is unrevealing, emphasizing need for comprehensive evaluation including neuromuscular assessment.
- Practice Integration: Include myasthenia gravis in differential diagnosis algorithms for acute respiratory failure presentations, particularly when accompanied by dysphagia, fever, or progressive weakness without clear pulmonary pathology.
- Risk Management: Establish protocols for rapid nerve conduction studies and AChR antibody testing in emergency settings when unexplained respiratory distress occurs, enabling timely ICU triage and acetylcholinesterase inhibitor therapy.
- Emergency Recognition: Train emergency clinicians to recognize Modified Medical Research Council Dyspnea Scale scores of 3-4 as potential neurological emergencies requiring immediate neuromuscular evaluation beyond standard cardiopulmonary assessment.
More in Pulmonology
PATIENT EDUCATION
OBESITY/WEIGHT MANAGEMENT
EXERCISE/TRAINING
LEGAL MATTERS
GUIDELINES/RECOMMENDATIONS